Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Eliglustat, common blend proposed commercial formulation
Total 1 results
Genzyme, a Sanofi Company
Completed
A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult Subjects
Healthy Volunteer
United States
Sponsors and Collaborators
Federal Agency for Disruptive Innovation - SPRIN-D
Red Deer Regional Hospital Centre, Red Deer, AB
Children's Health Andrews Institute for Orthopaedics & Sports Medicine
Alaa E Ahmed
Collabring Consultancy Pte Ltd
AMO Pharma
TypeZero Technologies, LLC
Maquet Cardiovascular
Dongguan Hospital of Traditional Chinese Medicine
Orthocon, Inc.
Aspirus Wausau Hospital
Portuguese Oncology Institute, Coimbra
Region Halland
siRNAgen Therapeutics Inc.
Neurologisches Therapiezentrum Gmundnerberg
Virdi Eye Clinic
AESCA Pharma GmbH
Policlinico Universitario, Catania
Tove Dragesund
Fysiotherapie zesgehuchten
View Full List
Medical Conditions
Resuscitation Orders for Critically Ill Patients
Steroid Abuse
Activating EGFR Mutation
Colonic Stricture
Postoperative Atrial Fibrilation
Tenotomy
Urinary Frequency
Chronic Pediatric Heart Failure
Physical Examination
Once a Preterm Developed Hypoglycemia, no More Blood Glucose Was Measured During the Study Period.
Nasopharyngeal Obstruction
Peri-Implant Health
Amount of Pioglitazone in Blood
Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention
Gram Positive Infection
Non-small Cell Lung Cancer Stage ⅢA
Recurrent Vestibulopathy
MSH6 Gene Mutation
Hemophagocytic Syndrome (HPS)
Indication for Cardiac Resynchronization Therapy (CRT)
View Full List
Drug Interventions
Nephrovit
Paracetamol and metamizole
MK-3475
Tranexamic acid injection
GS-9451
NALTREXONE
Ketorolac Pill
Tazemetostat
Cysteamine
(S)-ketamine (Main study)
Fosaprepitant,ondansetron, dexamethasone
Daptomycin 6 mg/kg IV
Bortezomib
Hyperthermic Intraperitoneal Chemotherapy
NO clamp
PF-04449913, ketoconazole
PIPERACILLIN-TAZOBACTAM
Cholecalciferol 50,000 IU
Cannabidiol oral solution
Allisartan Isoproxil
View Full List
CROs by country
Contract Research Organizations in Ecuador
Contract Research Organizations in Estonia
Contract Research Organizations in Gabon
Contract Research Organizations in Gambia
Contract Research Organizations in Ghana
Contract Research Organizations in Liberia
Contract Research Organizations in Nigeria
Contract Research Organizations in South Korea
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Taiwan
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uzbekistan
Contract Research Organizations in Vietnam
CRO list by country
CROs in Moldova
PSI
SGS
Dokumeds
SanaClis
BiTrial Clinical Research
All CROs in Moldova
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe